Get started
Author

Chris Fourment

Observed name: Fourment Chris
OpenAlex ID: A5045834603
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study
2021 · Brian Bressler, Andres Yarur, et al. · Journal of Crohn s and Colitis · 150
PDF
Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy
2018 · Timothy E. Ritter, Chris Fourment, et al. · The American Journal of Gastroenterology · 6
Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned
2017 · Anita Afzali, Matthew A Ciorba, et al. · Inflammatory Bowel Diseases · 5
Fatty Pancreas as a Reversible Cause of Exocrine Pancreatic Insufficiency: A Case Series
2018 · Dustin Kiker, Alexander Pieper, et al. · The American Journal of Gastroenterology · 4
728 Second-Line Biologic Therapy After Vedolizumab
2019 · Timothy E. Ritter, Chris Fourment, et al. · The American Journal of Gastroenterology · 3
P189 Real World Evaluation of Prolonged Clinical Response With Vedolizumab in Crohn’s Disease and Ulcerative Colitis Patients Treated in a Private Practice Setting
2018 · Timothy E. Ritter, Chris Fourment, et al. · Gastroenterology · 3
P100 Real-world Comparison of Arthralgias With Infliximab Vs. Vedolizumab in the Treatment of Bio-naive Inflammatory Bowel Disease
2020 · Timothy Ritter, Chris Fourment, et al. · Inflammatory Bowel Diseases · 2
S766 Artificial Intelligence (AI) in Endoscopy to Aid in Clinical Trial Recruitment in Inflammatory Bowel Disease (IBD)
2023 · William Holderman, Parth Jain, et al. · The American Journal of Gastroenterology · 1
P189 Real World Evaluation of Prolonged Clinical Response With Vedolizumab in Crohn’s Disease and Ulcerative Colitis Patients Treated in a Private Practice Setting
2018 · Timothy E Ritter, Chris Fourment, et al. · Inflammatory Bowel Diseases · 1
Long-term Safety Analysis of Vedolizumab for Treatment of Crohnʼs Disease and Ulcerative Colitis
2017 · Timothy E. Ritter, Chris Fourment, et al. · The American Journal of Gastroenterology · 1
S1315 Past the Pandemic: The Impact at One Year of COVID-19 on a Large Vertically Integrated Gastroenterology Community Practice, Future Implications, and Trends
2021 · William H. Holderman, Parth Jain, et al. · The American Journal of Gastroenterology
Fr061 COLOGUARD ORDERING PATTERNS AND DETECTION OF ADENOMATOUS POLYPS AND ADENOCARCINOMAS WITHIN A LARGE, SINGLE-SPECIALTY GASTROENTEROLOGY PRACTICE
2021 · Charles C. Owen, Chris Fourment, et al. · Gastroenterology
P100 Real-world Comparison of Arthralgias With Infliximab Vs. Vedolizumab in the Treatment of Bio-naive Inflammatory Bowel Disease
2020 · Timothy Ritter, Chris Fourment, et al. · Gastroenterology
P079 Real-World Prescribing Patterns of Certolizumab in the Treatment of Crohn’s Disease
2019 · Timothy Ritter, Chris Fourment, et al. · The American Journal of Gastroenterology
3159 A Case of Takayasu's Arteritis in a Patient With Crohn's Disease
2019 · Bitaal Sadiq, Chris Fourment, et al. · The American Journal of Gastroenterology
663 Onset of Response With Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease
2019 · Chris Fourment, Timothy E. Ritter, et al. · The American Journal of Gastroenterology
147 Colorectal Mucosal Schwann Cell Hamartomas in a Community Gastroenterology Practice
2019 · Bitaal Sadiq, Matthew Nunez, et al. · The American Journal of Gastroenterology
Therapeutic Drug Monitoring of Biologics in Patients With Inflammatory Bowel Disease: A Real World Experience
2018 · Chris Fourment, Timothy E. Ritter, et al. · The American Journal of Gastroenterology
Use of Therapeutic Drug Monitoring (TDM) to Aid Treatment Decision Making: A Retrospective View From a Large Community Practice
2018 · Fourment Chris, Pieper Alexander, et al. · The American Journal of Gastroenterology
Can Vedolizumab Non-Responders Be Treated Successfully With Another Biologic Agent?
2017 · Timothy E. Ritter, Chris Fourment, et al. · The American Journal of Gastroenterology
IBData, a Wearable Application for Patients With Inflammatory Bowel Disease: Platform Design and Clinical Characteristics of Patients
2017 · Chris Fourment, Dawn B. Beaulieu, et al. · The American Journal of Gastroenterology
Mo1292 Colonic Lymphoma: Diagnosis on Screening Colonoscopy
2016 · Arya L. Wibisono, Cory A. Roberts, et al. · Gastroenterology
Initial Diagnosis of a Common Hematological Malignancy in a Screening Colonoscopy
2015 · Timothy Ritter, Mahsa Sorouri, et al. · The American Journal of Gastroenterology
Melanosis Coli and Tubular Adenomas: A Microscopic Evaluation
2015 · Timothy Ritter, Mahsa Sorouri, et al. · The American Journal of Gastroenterology
Melanosis Coli in Microscopic Colitis
2015 · Timothy Ritter, Mahsa Sorouri, et al. · The American Journal of Gastroenterology
Works count: 25
Citation count: 176
H-index: 4
I10-index: 1
Year
Topic
Type